Based on the intersection of interleukin superfamily signature between human BC tissues and cell lines (Figure 2D) to exclude the tumor heterogeneity, both TNBC tissues and cell lines dominantly expressed IL1A, IL1B, IL8, and IL32 (Figure 2D). The gene discussed is IL32; the disease is neoplasm.